Innodata Isogen, Inc. – Trademark Portfolio
Entity Type: 03
Innodata Isogen, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include INNODATA. The owner is based in Hackensack, NJ.
Three University Plaza
Hackensack, NJ 07601
Showing of trademarks Trademarks
Trademark Classifications
Innodata Isogen, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Innodata Isogen, Inc. have?
Innodata Isogen, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 abandoned, 4 cancelled.
What trademark classes does Innodata Isogen, Inc. file in?
Innodata Isogen, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment), Class 40 (Treatment & Processing). Class 35 covers advertising; business management; business administration; office functions.
What are Innodata Isogen, Inc.'s most well-known trademarks?
Innodata Isogen, Inc.'s registered trademark portfolio includes well-known marks such as INNODATA. These are among 1 currently registered trademark in the portfolio.
What is Innodata Isogen, Inc.'s trademark registration success rate?
Innodata Isogen, Inc. has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.